Næste

Automatisk afspilning

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 Visninger • 07/14/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning